Matinas BioPharma Holdings, Inc.
Pharmaceutical company · Bedminster, New Jersey, United States · NYSE: MTNB
Matinas BioPharma Holdings, Inc. is a pharmaceutical company headquartered in Bedminster, New Jersey, United States. Its earliest recorded incorporation is in 2013. Its shares trade on NYSE under the ticker MTNB. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2025.
Matinas BioPharma Holdings at a glance
What does Matinas BioPharma Holdings do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $1.6 million sold (2025).
Frequently asked questions about Matinas BioPharma Holdings
Where is Matinas BioPharma Holdings headquartered?
Matinas BioPharma Holdings, Inc. is headquartered in Bedminster, New Jersey, United States.
What does Matinas BioPharma Holdings do?
Matinas BioPharma Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Matinas BioPharma Holdings a public company?
Yes. Matinas BioPharma Holdings, Inc. trades on NYSE under the ticker MTNB.
When was Matinas BioPharma Holdings founded?
The earliest incorporation on record for Matinas BioPharma Holdings, Inc. is in 2013, according to public company registers.
Similar companies
- Intra-Cellular Therapies, Inc.Bedminster, New Jersey, United States
- Retrieve Medical Holdings, Inc.Bedminster, New Jersey, United States
- Tyme Technologies, Inc.Bedminster, New Jersey, United States
- Castle Creek Pharmaceuticals, LLCBedminster, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences